CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz
Media Pack
News

Current Edition

Volume 18 Issue 3

Current Edition

Volume 18 Issue 3

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Designing Smart Integrated Drug Delivery Systems
Volume 9 Issue 4

Designing Smart Integrated Drug Delivery Systems

Wearable drug delivery technology is a good example of how drug delivery technology providers continue to stay ahead of the curve. In his piece, Graham Reynolds of G...
4 January 2018 Volume 9 Issue 4 delivery | designing
Continue Reading →
News

BIOCAD launches the new manufacturing site in North Africa

Russian biotechnology company BIOCAD and Moroccan pharmaceutical company Sothema Labs announced the launch of medicines derived using the technology provided by the ...
29 November 2017 News biosimilars | biotechnology
Continue Reading →
News

TraceLink webinar preview of the 2017 Global Drug Supply, Safety and Traceability Survey

The company's CEO, Shabbir Dahod, is hosting the webinar, which will preview the results of the company’s 2017 Global Drug Supply, Safety and Traceability Survey. Th...
24 November 2017 News drug | serialisation
Continue Reading →
News

TiGenix announces approval of trade name for lead development candidate Cx601 in Europe

TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-...
20 November 2017 News allogeneic | anti-inflammatory
Continue Reading →
News

Sanofi and Principia agree to develop MS drug candidate

Sanofi will develop Principia Biopharma Inc.'s experimental oral treatment that shows promise in multiple sclerosis (MS) and, potentially, other central nervous syst...
9 November 2017 News autoimmune | central nervous system
Continue Reading →
News

Immuno-oncology CRO secures Macrophage Pharma agreement

Aquila BioMedical Ltd., an innovative preclinical contract research organisation (CRO) now part of Concept Life Sciences group, has secured an extended agreement wit...
9 November 2017 News biotech | CRO
Continue Reading →
Centralised ECGs Help Ensure Cardiac Safety of Obesity Drugs
Clinical Research v4i3

Centralised ECGs Help Ensure Cardiac Safety of Obesity Drugs

Obesity rates have dramatically increased over the past 20 years, making it one of the most prevalent health problems in the world. Despite this, there are only ...
28 September 2012 Clinical Research v4i3 | Volume 4 Issue 3 cardiac | drug
Continue Reading →
Extending Your Patent on a New Application for an Old Drug
Regulatory & Marketplace v4i3

Extending Your Patent on a New Application for an Old Drug

Extending Your Patent on a New Application for an Old Drug     The period that is necessary to obtain a marketing authorisation to bring a n...
28 September 2012 Regulatory & Marketplace v4i3 | Volume 4 Issue 3 application | drug
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026